Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 2: Diagnosis, Therapeutic Targets, and Molecular Mechanisms
Editat de Ganji Purnachandra Nagaraju, Ramakrishna Vaddeen Limba Engleză Hardback – apr 2022
This book is a valuable resource for cancer researchers, oncologists, graduate students, hepathologists and members of biomedical research who need to understand more about liver cancer to apply in their research work or clinical setting.
- Provides detailed information on traditional and novel diagnostic tools for hepatocellular carcinoma
- Discusses promising targeted therapies, both available and in development, explaining the best option to use for specific cases
- Brings recent findings in immunotherapies, immune checkpoint inhibitors and nanotechnology-based therapeutic approaches for treatment of HCC
Preț: 746.89 lei
Preț vechi: 820.75 lei
-9% Nou
Puncte Express: 1120
Preț estimativ în valută:
142.94€ • 147.96$ • 120.81£
142.94€ • 147.96$ • 120.81£
Carte tipărită la comandă
Livrare economică 26 februarie-12 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323988070
ISBN-10: 0323988075
Pagini: 398
Dimensiuni: 191 x 235 mm
Greutate: 0.89 kg
Editura: ELSEVIER SCIENCE
ISBN-10: 0323988075
Pagini: 398
Dimensiuni: 191 x 235 mm
Greutate: 0.89 kg
Editura: ELSEVIER SCIENCE
Public țintă
Cancer researchers, oncologistsMedical doctors, hepathologists, graduate students
Cuprins
1. Hepatocellular carcinoma diagnosis2. Computational analysis of prognosisrelated genes in liver cancer3. Computational approaches to identify biomarkers, enzymes, and pathways of hepatocellular carcinoma4. Ribonucleic acid sequence analysis in deciphering hepatocellular carcinoma5. Hepatocarcinogenesis and the role of next-generation sequencing in liver cancer6. Liver cancer: the tumor microenvironment and associated pathways7. Metabolic pathway-based target therapy to hepatocellular carcinoma: a computational approach8. Targeting ion channels in hepatic cancer9. Tyrosine kinases: their role in hepatocellular carcinoma10. Role of transcription factors in hepatocellular carcinoma11. Modulatory act of diverse transcriptional factors in liver carcinoma12. Association of specificity protein 1 with hepatocellular carcinoma13. Promising biomarkers for liver cancer14. Molecular signaling and its role in drug resistance in hepatocellular carcinomas15. Multidrug resistance, a major obstacle in hepatocellular carcinoma treatment: challenges and future perspectives16. Proliferative signaling pathways in hepatocellular carcinoma17. Targeting angiogenesis in hepatocellular carcinoma18. Conventional and novel biomarkers for the diagnosis and prognosis of liver cancer19. Updates on the staging and treatment of hepatocellular carcinoma20. ROS-mediated pathways: potential role in hepatocellular carcinoma biology and therapy21. Dysregulated cell-signaling pathways in hepatocellular carcinoma: causes and therapeutic options22. LKB1/STK11-mediated signal transduction in hepatocellular carcinoma